BioCentury
ARTICLE | Company News

Pfizer, World Federation of Hemophilia (WFH) hematology news

October 29, 2012 7:00 AM UTC

Pfizer is donating more than 35 million IUs of recombinant Factor IX therapy to the non-profit to help hemophilia B patients in underserved regions of the world. The WFH is a network of patient organ...